Bristol Myers Squibb (BMY) Net Cash Flow Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
-568.73% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-85.99% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
1,265.92% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-95.55% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
191.97% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
103.60% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
42.41% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-227.06% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-227.06% |
| Dec 31, 2025 |
-311.96% |
| Sep 30, 2025 |
105.20% |
| Jun 30, 2025 |
153.32% |
| Mar 31, 2025 |
121.59% |
| Dec 31, 2024 |
-32.84% |
| Sep 30, 2024 |
285.59% |
| Jun 30, 2024 |
-390.41% |
| Mar 31, 2024 |
-637.93% |
| Dec 31, 2023 |
204.24% |
| Sep 30, 2023 |
72.11% |
| Jun 30, 2023 |
60.27% |
| Mar 31, 2023 |
83.39% |
| Dec 31, 2022 |
159.27% |
| Sep 30, 2022 |
-217.01% |
| Jun 30, 2022 |
-2,768.97% |
| Mar 31, 2022 |
51.69% |
| Dec 31, 2021 |
109.87% |
| Sep 30, 2021 |
570.92% |
| Jun 30, 2021 |
-98.57% |
| Mar 31, 2021 |
-203.46% |
| Dec 31, 2020 |
71.86% |
| Sep 30, 2020 |
-125.31% |
| Jun 30, 2020 |
-80.75% |
| Mar 31, 2020 |
729.69% |
| Dec 31, 2019 |
-1,266.67% |
| Sep 30, 2019 |
411.17% |
| Jun 30, 2019 |
6,984.31% |
| Mar 31, 2019 |
567.78% |
| Dec 31, 2018 |
93.24% |
| Sep 30, 2018 |
-64.14% |
| Jun 30, 2018 |
31.39% |
| Mar 31, 2018 |
74.65% |
| Dec 31, 2017 |
-8.20% |
| Sep 30, 2017 |
134.49% |
| Jun 30, 2017 |
-252.22% |
| Mar 31, 2017 |
-243.15% |
| Dec 31, 2016 |
158.53% |
| Sep 30, 2016 |
305.88% |
| Jun 30, 2016 |
114.01% |
| Mar 31, 2016 |
-64.47% |
| Dec 31, 2015 |
-310.84% |
| Sep 30, 2015 |
-144.16% |
| Jun 30, 2015 |
-122.32% |
| Mar 31, 2015 |
-57.36% |
| Dec 31, 2014 |
-61.68% |
| Sep 30, 2014 |
1,383.33% |
| Jun 30, 2014 |
-308.19% |
| Mar 31, 2014 |
626.37% |
| Dec 31, 2013 |
1,065.16% |
| Sep 30, 2013 |
96.79% |
| Jun 30, 2013 |
-11.37% |
| Mar 31, 2013 |
91.05% |
| Dec 31, 2012 |
-88.16% |
| Sep 30, 2012 |
-257.40% |
| Jun 30, 2012 |
100.79% |
| Mar 31, 2012 |
-110.92% |
| Dec 31, 2011 |
151.37% |
| Sep 30, 2011 |
-49.11% |
| Jun 30, 2011 |
-67.93% |
| Mar 31, 2011 |
35.14% |
| Dec 31, 2010 |
-294.36% |
| Sep 30, 2010 |
239.33% |
